share_log

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.6%

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.6%

紐約證券交易所代碼:RBOT 代替外科手術股價下跌 4.6%
Defense World ·  2023/01/31 01:52

Vicarious Surgical Inc (NYSE:RBOT – Get Rating) shares were down 4.6% during trading on Monday . The stock traded as low as $2.66 and last traded at $2.68. Approximately 144,413 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 372,564 shares. The stock had previously closed at $2.81.

Surgical公司(紐約證券交易所代碼：RBOT-GET)的股票在週一的交易中下跌了4.6%。該股一度跌至2.66美元，最後報2.68美元。午盤成交量約為144,413股，較372,564股的日均成交量下降61%。該股此前收盤價為2.81美元。

Vicarious Surgical Price Performance

替代手術性價比

The firm has a market cap of $327.95 million, a price-to-earnings ratio of 3.77 and a beta of 1.09. The business has a fifty day simple moving average of $2.56 and a 200 day simple moving average of $3.35.

該公司市值為3.2795億美元，市盈率為3.77倍，貝塔係數為1.09。該業務的50日簡單移動均線切入位為2.56美元，200日簡單移動均線切入位為3.35美元。

Get
到達
Vicarious Surgical
代替性外科
alerts:
警報：

Vicarious Surgical (NYSE:RBOT – Get Rating) last released its quarterly earnings results on Monday, November 7th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.03). During the same period in the previous year, the firm earned ($0.09) earnings per share. On average, research analysts anticipate that Vicarious Surgical Inc will post -0.66 earnings per share for the current fiscal year.

Surgical(紐約證券交易所代碼：RBOT-GET Rating)最近一次發佈季度收益報告是在11月7日星期一。該公司公佈本季度每股收益(EPS)為0.18美元，低於分析師一致預期的0.15美元和0.03美元。去年同期，該公司每股收益為0.09美元。研究分析師平均預計，維珍外科公司本財年的每股收益將為0.66美元。

Insider Buying and Selling at Vicarious Surgical

代理外科公司的內幕買賣

In other news, Director Philip Liang sold 15,000 shares of the stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $3.59, for a total value of $53,850.00. Following the completion of the transaction, the director now directly owns 1,185,320 shares in the company, valued at $4,255,298.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at
在其他新聞方面，董事菲利普·樑在11月10日星期四的一筆交易中出售了15,000股該股。這些股票的平均價格為3.59美元，總價值為53,850.00美元。交易完成後，董事現在直接擁有該公司1185,320股票，價值4,255,298.80美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，該文件可在
this hyperlink
此超鏈接
. In other Vicarious Surgical news, Director Philip Liang sold 15,000 shares of Vicarious Surgical stock in a transaction on Thursday, November 10th. The shares were sold at an average price of $3.59, for a total transaction of $53,850.00. Following the completion of the sale, the director now owns 1,185,320 shares of the company's stock, valued at approximately $4,255,298.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at
。另有消息稱，11月10日(星期四)，董事菲利普·樑在一筆交易中出售了15,000股代理外科股票。這些股票以3.59美元的平均價格出售，總成交金額為53,850.00美元。出售完成後，董事現在擁有1,185,320股該公司股票，價值約4,255,298.80美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可在
this link
這個環節
. Also, CTO Sammy Khalifa sold 18,041 shares of Vicarious Surgical stock in a transaction on Monday, November 21st. The shares were sold at an average price of $3.29, for a total transaction of $59,354.89. Following the sale, the chief technology officer now directly owns 994,493 shares of the company's stock, valued at approximately $3,271,881.97. The disclosure for this sale can be found
。此外，首席技術官薩米·哈利法在11月21日星期一的一次交易中出售了18,041股代理外科股票。這些股票以3.29美元的平均價格出售，總成交金額為59,354.89美元。出售後，這位首席技術官現在直接持有該公司994,493股股票，價值約3,271,881.97美元。關於這次銷售的披露可以找到
here
這裏
. Insiders sold a total of 117,873 shares of company stock valued at $376,819 in the last ninety days. Insiders own 52.48% of the company's stock.
。在過去的90天裏，內部人士總共拋售了117,873股公司股票，價值376,819美元。內部人士持有該公司52.48%的股份。

Institutional Trading of Vicarious Surgical

代用外科手術的制度性交易

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RBOT. International Assets Investment Management LLC acquired a new position in Vicarious Surgical during the fourth quarter worth $27,000. Strs Ohio increased its holdings in Vicarious Surgical by 395.3% in the 4th quarter. Strs Ohio now owns 62,900 shares of the company's stock valued at $127,000 after buying an additional 50,200 shares during the period. Rothschild Investment Corp IL increased its holdings in Vicarious Surgical by 28.5% in the 4th quarter. Rothschild Investment Corp IL now owns 168,831 shares of the company's stock valued at $341,000 after buying an additional 37,417 shares during the period. Twelve Points Wealth Management LLC increased its holdings in Vicarious Surgical by 86.0% in the 4th quarter. Twelve Points Wealth Management LLC now owns 100,473 shares of the company's stock valued at $203,000 after buying an additional 46,462 shares during the period. Finally, Riverwater Partners LLC grew its holdings in shares of Vicarious Surgical by 63.0% during the 4th quarter. Riverwater Partners LLC now owns 27,853 shares of the company's stock valued at $56,000 after purchasing an additional 10,762 shares during the last quarter. Institutional investors own 42.77% of the company's stock.

一些機構投資者和對衝基金最近增持或減持了RBOT的股份。國際資產投資管理有限責任公司在第四季度獲得了一個新的頭寸，價值27,000美元。俄亥俄州STRS在第四季度增持了395.3%的Surgical。STR俄亥俄州現在擁有62,900股該公司的股票，價值12.7萬美元，在此期間又購買了50,200股。Rothschild Investment Corp IL在第四季度增持了Surgical公司28.5%的股份。Rothschild Investment Corp IL目前持有168,831股該公司股票，價值341,000美元，在此期間又購買了37,417股。十二點財富管理有限責任公司第四季度增持維信外科86.0%的股份。十二點財富管理公司現在擁有100,473股該公司的股票，價值203,000美元，在此期間又購買了46,462股。最後，Riverwater Partners LLC在第四季度增持了Vicary Surgical的股份63.0%。Riverwater Partners LLC現在擁有27,853股該公司的股票，價值56,000美元，在上個季度又購買了10,762股。機構投資者持有該公司42.77%的股票。

Vicarious Surgical Company Profile

代理外科公司簡介

(Get Rating)

(獲取評級)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

替代外科公司在美國作為一家機器人技術公司運營。該公司專注於開發和商業化維多利亞系統，這是一種單切口手術機器人，可以虛擬地將外科醫生運送到患者體內進行微創手術。Surgical Inc.成立於2014年，總部設在馬薩諸塞州沃爾瑟姆。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Vicarious Surgical (RBOT)
  • Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
  • SoFi Technologies Smashes Earnings but Beware the Fed Decision
  • Buying The Dip In Colgate-Palmolive
  • Mullen Automotive On Hiring Spree, What Could That Mean?
  • InterDigital Raises Its Earnings Guidance
  • 免費獲取StockNews.com關於替代外科手術(RBOT)的研究報告
  • 為什麼黃金現在可以成為你投資組合中的閃閃發光的一部分
  • 索菲技術公司盈利慘淡，但要警惕美聯儲的決定
  • 購買高露潔棕欖中的Dip
  • 馬倫汽車(Mullen Automotive)大舉招聘，這可能意味着什麼？
  • InterDigital上調盈利指引

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《替代外科日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收對替代外科及相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論